Specialty pharma company Assertio Holdings has expanded its portfolio through a deal with Aquestive Therapeutics, paying $9 million upfront for exclusive rights to the Sympazan oral film formulation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback